Snapshot from Jul 26, 2026 at 07:00 UTC. For live data and tracking: View Live
Business corporate name change

Adia Nutrition renamed to Adia Med

Analysis based on 8 articles · First reported Jul 07, 2026 · Last updated Jul 09, 2026

Sentiment
10
Attention
0
Articles
8
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The name change is a minor corporate event with limited market impact. It may slightly improve brand recognition for Adia Med Inc. among investors focused on regenerative medicine.

Healthcare Biotechnology

Adia Nutrition Inc. (OTCQB: ADIA) has completed its corporate name change to Adia Med Inc. after FINRA approved the change on an expedited timeline. The name change was reflected on the FINRA Daily List on July 9, 2026, with trading under the new name expected to begin on July 10, 2026. The company, based in Winter Park, Florida, specializes in stem cell and regenerative therapies, and the rebranding aligns its corporate identity with its healthcare mission. CEO Larry Powalisz expressed gratitude to VStock Transfer and FINRA for facilitating the transition.

100 Adia Nutrition changed name to Adia Med
30 VStock Transfer confirmed FINRA approval Adia Nutrition
20 Larry Powalisz announced name change
stock
Adia Nutrition is the entity undergoing the name change; it will cease to exist as a legal name and be replaced by Adia Med.
Importance 100.0 Sentiment 10.0
stock
Adia Med is the new corporate name, reflecting the company's focus on medical and regenerative therapies.
Importance 100.0 Sentiment 10.0
govactor
FINRA reviewed and approved the name change on an expedited timeline, facilitating the corporate action.
Importance 50.0 Sentiment 0.0
per
Larry Powalisz is the CEO who announced the name change and expressed satisfaction with the process.
Importance 30.0 Sentiment 0.0
exch
OTC Markets Group will list the company under the new name Adia Med Inc. starting July 10, 2026.
Importance 30.0 Sentiment 0.0
priv
VStock Transfer acted as transfer agent, confirming FINRA's approval to the company.
Importance 20.0 Sentiment 0.0
priv
Adia Labs is a division of the company that sells stem cell and regenerative products; the name change does not directly affect its operations.
Importance 10.0 Sentiment 0.0
priv
Cement Factory LLC is an investment of Adia Med; the name change has no direct impact on it.
Importance 5.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.